Skip to main content
Clinical Trials/JPRN-UMIN000038574
JPRN-UMIN000038574
Completed
N/A

Exploratory study to investigate biomarkers associated with pathogenesis of infantile hemangioma. - Exploratory study to investigate biomarkers associated with pathogenesis of infantile hemangioma.

Wakayama Medical University0 sites45 target enrollmentNovember 13, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Infantile hemangioma
Sponsor
Wakayama Medical University
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 13, 2019
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Internal type 2\)Patients who need to start treatment of infantile hemangioma before proliferating phase and the initiation of study. 3\)Patients taking medications that may affect infantile hemangioma pathology and levels of biomarker before the study 4\)Patients suspected of serious complications and diseases that greatly affect cytokine levels through interview by the doctors (PHACE syndrome, infection and inflammatory diseases, etc).

Outcomes

Primary Outcomes

Not specified

Similar Trials